Interferential effect of the over-erupted third molar on chewing movement

OBJECTIVE

To clarify whether over-eruption of the mandibular third molar can disturb chewing movement.

METHODS

Eighteen patients with a unilateral mandibular over-erupted third molar confirmed by both study cast observation and T-scan occlusal detection were selected from a sample of patients with complaints of temporomandibular disorder (TMD) symptoms. A unilateral gum-chewing trace was recorded separately for left and right side chewing by an electrognathography system. The average chewing pattern (ACP) was created based on segments from the recorded chewing trace to represent the chewing movement characteristics of each individual. Two factors, the TMD symptomatic side and the over-eruption side, were analysed for their effects on values of difference in the parameters (Δvalue) regarding the ACP between chewing with right and left side. Three-dimensional amplitudes of ACP and the cross point value of ACP with the vertical axis (termed the cross zero point value) which described the turning point of the chewing cycle from the balancing side to the working side, were compared between sides.

RESULTS

The over-eruption side had an effect on the Δvalue of the medial amplitude, the lateral amplitude, and the cross zero point (P<0.05), but the symptomatic side didn't (P>0.05). When chewing on the over-eruption side, the medial amplitude was shorter, the lateral amplitude was larger, and the cross zero point value was smaller than those when chewing on the other side (P<0.05).

CONCLUSION

The present data indicate an effect of the over-erupted mandibular third molar on the chewing pattern while that from the symptom(s) is limited.

Are certain factors involved in calcium metabolism associated with temporomandibular disorders?

Objective: The aim of the present study was to investigate whether there is an association between serum concentrations of calcium, phosphate, alkaline phosphatase, parathyroid hormone (PTH), and vitamin D and temporomandibular disorders (TMDs).Methods: In this case-control study, 51 patients with TMDs (28 patients with TMJ clicking, 5 patients with muscular disorders, and 18 osteoarthritis patients) and 29 healthy subjects within the age range of 20-50 years as the control group, were referred to the laboratory for calcium, phosphate, alkaline phosphatase, PTH, and vitamin D (25 OHD) analysis tests. The TMJ status of all participants was examined according to RDC-TMD criteria by a prosthodontist who is an expert in TMDs. The results were analyzed with Fisher's precise test.Results: No statistically significant difference was observed between TMD patients and healthy subjects.Conclusion: Serum concentrations of calcium, phosphate, alkaline phosphatase, PTH, and vitamin D are not associated with TMDs.

Efficacy of therapeutic exercise for temporomandibular disorders as assessed by magnetic resonance imaging: a case report

[Purpose] The efficacy of exercise therapy in temporomandibular disorders has been recognized. Here, we present our experience with exercise therapy. [Participant and Methods] A 25-year-old female with a sudden onset of mouth opening limitation in October 2018 was admitted to our hospital in November 2018. Based on our initial findings, the patient was diagnosed with left disc derangement of the temporomandibular joint without reduction. A definitive diagnosis was established following magnetic resonance imaging in December 2018. Subsequently, range-of-motion exercises for the temporomandibular joint as passive movements and self-traction therapy as active movements were conducted. Magnetic resonance imaging was repeated 4 months after the first treatment. [Results] The temporomandibular joint disc remained in anterior dislocation during mouth opening and closing. The mouth opening joint motion was significantly improved compared to the pre-therapy range. The pain-related visual analog scale score also significantly improved. [Conclusion] The range of motion of the temporomandibular joint was improved by range-of-motion exercises for the temporomandibular joint, and was maintained and managed using self-traction therapy. Improvement of the range of motion was confirmed by magnetic resonance imaging.

Remodeling dental anatomy vs sham therapy for chronic temporomandibular disorders. A placebo-controlled randomized clinical trial

BACKGROUND

Evidence regarding the etiology or effective treatments for chronic orofacial pain, the majority diagnosed as temporomandibular disorder (TMD), is limited.

PURPOSE

To investigate whether occlusal equilibration therapy (ET) and decreasing the (higher) angle of the lateral guidance on the nonworking-side leads to a reduction in chronic TMDs intensity.

METHODS

It was conducted a randomized, explanatory, single blind with blinded assessment, placebo-controlled trial with strong protection against bias involving patients with chronic TMDs. Participants were randomly assigned to receive equilibration therapy or sham therapy. ET in this study consisted of minimal invasive occlusal remodeling to obtain balanced occlusion with reduction of the steeper angle of lateral mandibular movement with respect to the Frankfort plane. The primary outcome was a change in the pain intensity score (on a 0-10 point scale, with 0 indicating no pain and 10 the worst possible pain) at month 6. Secondary outcomes include maximum unassisted mouth opening and psychological distress.

RESULTS

A total of 77 participants underwent randomization, 39 of whom received ET and 38 sham therapy. The trial was stopped early for efficacy, according to preestablished rules when 67 participants (n = 34, n = 33, respectively) had completed the analysis. At month 6, the mean unadjusted pain intensity score was 2.1 in the ET and 3.6 in the sham therapy group (adjusted mean difference, -1.54; 95% confidence interval [CI] -0.5 to -2.6; P = 0.004; ANCOVA model). The mean increase in maximum unassisted mouth opening (main secondary outcome) was significantly higher in the real therapy group (adjusted mean difference 3.1 mm, 95% CI 0.5-5.7, p = 0.02).

CONCLUSION

ET significantly reduced the intensity of facial pain associated with chronic TMDs and increased maximum unassisted mouth opening, as compared with sham therapy, over the course of 6 months. There were no serious adverse events. Funded by the Instituto de Salud Carlos III from the Ministry of Science and Innovation of the Government of Spain and European Regional Development Fund, Grant nº PI11/02507; "una manera de hacer Europa".

The involvement of orexin-1 receptors in modulation of feeding and anxiety-like behavior in rats with complete Freund's adjuvant-induced temporomandibular joint disorder

Orexin-A (OXA), a neuropeptide produced in the hypothalamus, is recognized for its role in modulating orofacial nociception and regulating feeding behaviors, as well as its impact on psychophysiological responses. This study investigated the role of orexin-1 receptors (OX1R) in modulating nociceptive behaviors induced by noxious stimulation of the temporomandibular joint (TMJ) and the associated changes in mood and feeding behaviors in rats with complete Freund's adjuvant (CFA)-induced temporomandibular disorders (TMDs). Bilateral cannulation of the lateral ventricles was performed in rats. To induce nociception, CFA was injected unilaterally into the left TMJ of the rats. Nociceptive behaviors were assessed using the hot plate and tail flick tests, while anxiety-like behavior and food intake were evaluated using an elevated plus maze (EPM) and a food preference device, respectively. The results demonstrated a significant increase in nociceptive scores and anxiety-like behaviors, along with reductions in water and food consumption following CFA injection. However, post-treatment with OXA at concentrations of 50 and 100 pM/rat significantly decreased thermal nociceptive scores, alleviated anxiety-like behavior, and increased water and food intake. These beneficial effects were reversed when OXA was co-administered with SB-334867 (40 nM/rat), an OX1R antagonist. Collectively, our findings suggest that OX1R signaling plays a role in the modulation of anxiety-like behavior and abnormalities in food intake in CFA-treated rats. Understanding the involvement of OXA and its receptors in CFA-induced TMJ nociception and behavioral changes may pave the way for potential therapeutic interventions targeting OX1R signaling in the management of TMD-associated symptoms.